8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1ar,5s,8s,10r,22ar)-

8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1ar,5s,8s,10r,22ar)-

Cat. No.: PI1206524857

8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxylic acid, 5-(1,1-dimethylethyl)-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-14-methoxy-3,6-dioxo-, (1ar,5s,8s,10r,22ar)-
Product Details Other Identifiers Computed Properties
CAS 1206524-85-7
Purity 99%
Molecular Formula C29H38N4O7
Molecular Weight 554.63
Molar Refractivity 154.59
Pubchem ID 46930991
InChI Key IVROMYPOGKZNLP-FDOFPDFBSA-N
MDL Number MFCD31561044
Aromatic Heavy Atoms Number 10
BBB Permeant No
Bioavailability Score 0.56
Brenk 0.0 alert
Consensus Log Po/w 3.06
CYP1A2Inhibitor No
CYP2C19Inhibitor No
CYP2C9Inhibitor No
CYP2D6Inhibitor No
CYP3A4Inhibitor No
Egan 1.0
Fraction Csp3 0.62
Ghose None
GI Absorption Low
Heavy Atom Count 40
Hydrogen Bond Acceptor Count 9.0
Hydrogen Bond Donor Count 2.0
Leadlikeness 2.0
Lipinski 2.0
Log Kp (Skin Permeation) -6.39 cm/s
Log Po/w (iLOGP) 3.97
Log Po/w (MLOGP) 1.79
Log Po/w (SILICOS-IT) 1.95
Log Po/w (WLOGP) 2.96
Log Po/w (XLOGP3) 4.64
Muegge 0.0
PAINS 0.0 alert
P-gp Substrate Yes
Rotatable Bond Count 3
Synthetic Accessibility 6.9
Topological Polar Surface Area 140.18 Ų
Veber 1.0

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Verification code
For product and service inquiries icon1

For product and service inquiries, please use our online system or send an email to .

For product and service inquiries icon2